Marzena Wełnicka-Jaśkiewicz
Gdańsk Medical University(PL)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Cancer Cells and Metastasis, Cancer Diagnosis and Treatment
Most-Cited Works
- → Final Results of a Randomized Phase III Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With a Dose-Intensified Epirubicin and Cyclophosphamide + Filgrastim as Neoadjuvant Treatment in Locally Advanced Breast Cancer: An EORTC-NCIC-SAKK Multicenter Study(2003)228 cited
- → Quality indicators in breast cancer care(2010)206 cited
- → Health-Related Quality of Life Parameters As Prognostic Factors in a Nonmetastatic Breast Cancer Population: An International Multicenter Study(2004)118 cited
- → CD73 Expression as a Potential Marker of Good Prognosis in Breast Carcinoma(2011)88 cited
- → Gemcitabine, Epirubicin, and Paclitaxel Versus Fluorouracil, Epirubicin, and Cyclophosphamide As First-Line Chemotherapy in Metastatic Breast Cancer: A Central European Cooperative Oncology Group International, Multicenter, Prospective, Randomized Phase III Trial(2005)63 cited
- → Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients(2019)55 cited
- → Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial(2005)51 cited
- → Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer(2012)50 cited
- → Mesenchymal Phenotype of CTC-Enriched Blood Fraction and Lymph Node Metastasis Formation Potential(2014)49 cited
- Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation.(2014)